1. Home
  2. TCI vs LUNG Comparison

TCI vs LUNG Comparison

Compare TCI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcontinental Realty Investors Inc.

TCI

Transcontinental Realty Investors Inc.

HOLD

Current Price

$34.85

Market Cap

308.7M

Sector

Finance

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.33

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCI
LUNG
Founded
1983
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.7M
57.9M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TCI
LUNG
Price
$34.85
$1.33
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
2.4K
511.9K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
135.29
7.64
EPS
0.02
N/A
Revenue
$49,060,000.00
$90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
N/A
$18.46
P/E Ratio
$1,729.00
N/A
Revenue Growth
4.23
8.01
52 Week Low
$31.48
$1.13
52 Week High
$59.65
$3.88

Technical Indicators

Market Signals
Indicator
TCI
LUNG
Relative Strength Index (RSI) 41.40 50.04
Support Level $33.50 $1.27
Resistance Level $38.38 $1.45
Average True Range (ATR) 0.91 0.09
MACD -0.10 0.01
Stochastic Oscillator 17.52 55.56

Price Performance

Historical Comparison
TCI
LUNG

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates in two business segments: the acquisition, development, ownership and management of multifamily properties; and the acquisition, development, ownership and management of commercial properties; which are office properties. The services for its commercial segment include rental of office space and other tenant services, including parking and storage space rental. The services for its multifamily segment include rental of apartments and other tenant services, including parking and storage space rental. the company derives maximum revenue from Multifamily Segment.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: